HomeProductsBuilding BlocksHeterocyclic ScaffoldsAromatic HeterocyclesRobalzotan
Chemical structure of CAS 169758-66-1

Robalzotan

CAS No.169758-66-1
MDL No.N/A
MFC18H23FN2O2
MW318.40
InChI KeyMQTUXRKNJYPMCG-CYBMUJFWSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.169758-66-1
Product NameRobalzotan

Biological Targets

HTR1A
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.

The American journal of gastroenterology • Vol. 103, Issue 10 • 2008
PMID: 18775020DOI: 10.1111/j.1572-0241.2008.02115.x

Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.

Journal of pharmaceutical and biomedical analysis • Vol. 38, Issue 3 • 2005
PMID: 15925237DOI: 10.1016/j.jpba.2005.01.015

Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat.

Neuropharmacology • Vol. 48, Issue 6 • 2005
PMID: 15829255DOI: 10.1016/j.neuropharm.2005.01.007

Positron emission tomographic analysis of dose-dependent NAD-299 binding to 5-hydroxytryptamine-1A receptors in the human brain.

Psychopharmacology • Vol. 167, Issue 1 • 2003
PMID: 12632244DOI: 10.1007/s00213-002-1355-0

Documentation